Viral vectors displaying specific ligand binding moities such as scFv fragm
ents or intact antibodies hold promise for the development of targeted gene
therapy vectors. In this report we describe baculoviral vectors displaying
either functional scFv fragments or the synthetic Z/ZZ IgG; binding domain
derived from protein A. Display on the baculovirus surface was achieved ti
a fusion of the scFv fragment or Z/ZZ domain to the N-terminus of gp64, the
major envelope protein of the Autographa californica nuclear polyhedrosis
virus, AcNPV. As examples of scFv fragments we have used a murine scFv spec
ific for the hapten 2-phenyloxazolone and a human scFv specific for carcino
embryonic antigen. In principle, the Z/ZZ IgG binding domain displaying bac
uloviruses could be targeted to specific cell types via the binding of an a
ppropriate antibody. We envisage applications for scFv and Z/ZZ domain disp
laying baculoviral vectors in the gene therapy field. (C) 2000 Academic Pre
ss.